Coup de laser sur le T4, vision moyen terme confirmée - NEUTRE, OC 3,4€ vs 3,5€
Publié vendredi soir après bourse, le CA 2014 est inférieur à notre prévision de 54,9m€, à 51,3m€ (48,9m€ hors Alma Laser vs 52,9m€ attendu). Ceci est du en grande partie à une performance décevante en ophtalmologie. Cette contre performance ne remet pas significativement en cause nos perspectives d’activité 2015 et 2016. Nos estimations de résultats diminuent très significativement en 2014, et sont également ajustées sur les deux exercices suivants. Notre objectif de cours est diminué de 3,5€ à 3,4€. Opinion NEUTRE conservée.Quantel and its subsidiaries are engaged in the production, development and distribution of lasers for medical applications mainly in ophthalmology and dermatology. Co. produces lasers for scientific instrumentation involved in research and development and underwater lasers. Co. also provides laser impulses for industrial applications such as laser cleaning or material processing.
Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.
Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.